www.pharmablog.nl
Weblog met nieuws over de pharmaceutische industrie
Archive for February, 2009
Fitch rates $138M education bonds ‘very strong’
Author: admin24 Feb
Fitch Ratings gave a “AA” rating — very strong — to the Oregon board of higher education general obligation bonds.
IRS: Expect boost in paycheck this spring
Author: admin24 Feb
Millions of American workers will receive a boost in their paychecks this spring after the new withholding standards kick in from the economic stimulus package signed into law last week, according to the Internal Revenue Service.
Zonisamide (marketed as Zonegran, and generics)
Author: admin24 Feb
Audience: Neurological healthcare professionals [Posted 02/23/2009] FDA notified healthcare professionals that updated clinical data has determined that treatment with zonisamide, indicated as adjunctive therapy in the treatment of partial seizures…
Audience: Neurological healthcare professionals [Posted 02/23/2009] FDA notified healthcare professionals that updated clinical data has determined that treatment with zonisamide, indicated as adjunctive therapy in the treatment of partial seizures…
Lees meer..
Microsoft bungles severance pay
Author: admin24 Feb
Microsoft Corp. said it has overpaid some of its recently laid-off workers and is asking the workers to return part of their severance checks. (MSFT)
Genentech: Roche $42.1B offer too low
Author: admin24 Feb
Genentech Inc. said Monday it rejected a $42.1 billion hostile bid from Roche as being too low. (DNA)
ATS’ revenue, loss grow in Q4
Author: admin24 Feb
ATS Medical Inc.’s revenue surged 27 percent in the fourth quarter of 2008, but the company’s net loss still grew due to a one-time charge related to a legal settlement.
Genentech urges rejection of ‘inadequate’ Roche bid
Author: admin24 Feb
Genentech Inc. recommended on Monday that shareholders reject an $86.50-per-share offer from Roche Holding to buy the 44 percent of the South San Francisco biotech company that Roche doesn’t already own. (DNA)
Genentech: Roche $42.1B offer too low
Author: admin24 Feb
Genentech Inc. said Monday it rejected a $42.1 billion hostile bid from Roche as being too low. (DNA)
Report: Healh care crucial part of fixing economy
Author: admin24 Feb
A report released today by the Tennessee branch of Health Care for America says that fixing the health care system is a key to fixing the state’s and nation’s economy.
ICG Commerce in deal with Teva
Author: admin24 Feb
Procurement services company ICG Commerce said Monday it has signed a multimillion-dollar, five-year contract to manage part of Teva Pharmaceuticals’ indirect spending. (ICGE) (TEVA)